[Left main intervention: options and limitations in interventional cardiology]

E Boudriot1, H Thiele, G Schuler

  • 1Klinik für innere Medizin/Kardiologie, Universität Leipzig - Herzzentrum, Deutschland. boue@medizin.uni-leipzig.de

Herz
|May 14, 2011
PubMed

Insights

Percutaneous coronary intervention (PCI) is now recommended for selected patients with left main stenosis (LMS), offering an alternative to traditional coronary artery bypass graft (CABG) surgery for improved long-term survival.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Context:

  • Left main stenosis (LMS) necessitates revascularization for improved long-term survival.
  • Coronary artery bypass graft (CABG) surgery has been the standard treatment for LMS.
  • Percutaneous coronary intervention (PCI) is increasingly considered for selected LMS patients.

Purpose:

  • To evaluate the role and outcomes of PCI versus CABG in patients with left main stenosis.
  • To identify patient subgroups suitable for PCI in LMS based on anatomical complexity and surgical risk.
  • To provide evidence supporting updated clinical recommendations for LMS treatment.

Summary:

  • Recent studies and the SYNTAX Trial indicate PCI can yield good results in specific LMS patient subgroups.
  • Suitable candidates include those with isolated ostial LMS, LMS with single-vessel disease, low SYNTAX scores (<33), or high surgical risk.
  • CABG remains preferred for complex anatomy (SYNTAX score >33) or multi-vessel disease.

Impact:

  • PCI offers a viable revascularization option for carefully selected LMS patients, potentially expanding treatment choices.
  • Management decisions should involve a heart team approach in specialized centers with surgical backup.
  • Ongoing trials will further define the comparative efficacy of PCI versus CABG using hard clinical endpoints.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.